Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model
Experimental Lung Research · 28.05.2017 · 43 (4-5) · 187-196
DOI: 10.1080/01902148.2017.1339141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Lung Research, online erschienen am 11.07.2017. Verfasst von Hwa Young Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: a Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine , The Catholi…. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Nintedanib is a multi-tyrosine kinase receptor inhibitor recently approved for treatment of idiopathic pulmonary fibrosis. Although angiogenesis is a key process involved in airway structural changes in patients with bronchial asthma, the effect of nintedanib targeting the angiokinase pathway on airway inflammation and remodeling has not been evaluated. METHODS: We used a 3-month ovalbumin (OVA) challenge mouse model of airway remodeling. Nintedanib was orally administrated during the challenge period, and the effects were examined based on the percentage of airway inflammatory cells, airway hyper-reactivity (AHR), peribronchial goblet cell hyperplasia, total lung collagen and smooth muscle area. The expression of growth factor receptors was analyzed in mice lung tissues. RESULTS: The OVA challenged group showed a significant increase in airway eosinophilic inflammation, elevated Th2 cytokines, AHR, and airway remodeling compared to those in the control group. The airway remodeling process, as evaluated by goblet cell hyperplasia, total lung collagen level, and airway smooth muscle area, was suppressed by nintedanib compared to that by OVA. Nintedanib effectively suppressed the phosphorylation of vascular endothelial growth factor/ platelet derived growth factor subunit2/fibroblast growth factor3 receptors in the mice lung. CONCLUSIONS: Nintedanib effectively ameliorated airway inflammation and remodeling in an OVA-induced chronic asthma model. These results suggest that nintedanib could be a new treatment agent targeting airway remodeling in patients with severe asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- a Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine , The Catholic University of Korea , Gyeonggi-do , Republic of Korea.
- b Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.
- c Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Youido St. Mary's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.
- d Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine , The Catholic University of Korea , Gyeonggi-do , Republic of Korea.
ORCID-Profile: Chin Kook Rhee
Zitieren
APA
Lee, H. Y., Hur, J., Kim, I. K., Kang, J. Y., Yoon, H. K., Lee, S. Y., Kwon, S. S., Kim, Y. K., & Rhee, C. K. (2017). Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model. Experimental Lung Research, 43(4-5), 187-196. https://doi.org/10.1080/01902148.2017.1339141
Vancouver
Lee HY, Hur J, Kim IK, Kang JY, Yoon HK, Lee SY, et al. Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model. Experimental Lung Research. 2017;43(4-5):187-196. doi:10.1080/01902148.2017.1339141
BibTeX
@article{Lee2017,
author = {Lee, Hwa Young and Hur, Jung and Kim, In Kyoung and Kang, Ji Young and Yoon, Hyoung Kyu and Lee, Sook Young and Kwon, Soon Suk and Kim, Young Kyoon and Rhee, Chin Kook},
title = {Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model},
journal = {Experimental Lung Research},
year = {2017},
volume = {43},
number = {4-5},
pages = {187--196},
doi = {10.1080/01902148.2017.1339141}
}
EUVIMED